SCHEMBL4837253

SCHEMBL4837253

COC(=O)c1cccc(CCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3cccc(C(F)(F)F)c3)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.41
CACNA1B Q00975 1/20 0.39
NAMPT P43490 1/20 0.38
MAPK1 P28482 1/20 0.38
MAPT P10636 1/20 0.38
FKBP1A P62942 1/20 0.38
ADAMTS7 Q9UKP4 1/20 0.38
ADAMTS5 Q9UNA0 1/20 0.38
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
POLB P06746 1/20 0.37
MMP8 P22894 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4836346 0.93 RORC (0.42) RORCCACNA1BMAPT
SCHEMBL4845228 0.92 RORC (0.41) RORCNAMPTADAMTS7ADAMTS5PSEN1
SCHEMBL4837216 0.89 RORC (0.43) RORCCACNA1BMAPK1MAPTADAMTS7
SCHEMBL4833445 0.87 RORC (0.45) RORC
SCHEMBL4845363 0.87 RORC (0.43) RORCPSEN1PSEN2APH1BNCSTN
SCHEMBL4842798 0.87 PTPN1 (0.39) RORCPSEN1PSEN2APH1BNCSTN
SCHEMBL4842635 0.87 RORC (0.42) RORCMAPK1FKBP1AADAMTS7ADAMTS5
SCHEMBL4211574 0.86 MMP8 (0.41) RORCPSEN1PSEN2APH1BNCSTN
SCHEMBL4834335 0.85 RORC (0.39) RORCCACNA1BMAPK1MAPTPSEN1
SCHEMBL4841474 0.85 RORC (0.39) RORCCACNA1BMAPTPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 RORC 1777/4885CACNA1B 1324/4885NAMPT 2314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.